Arye Rubinstein, MD
Allergy & Immunology · Bronx, NYNPI 1831255777
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,750 of the $4,157 with a category attached, or 66.2%. Shire North American Group Inc accounts for 69.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $3,237 and has fallen 99.2% since, to $27 in 2025.
Across 77 payments — averaging $53.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$3K
- Takeda Pharmaceuticals U.S.A., Inc.$532
- AstraZeneca$195
- CSL Behring$164
- Novartis$151
- Grifols USA, LLC$74
- plus $157 from 4 others
Across 485 payments — averaging $2306.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$730K
- Shire North American Group Inc$331K
- Leadiant Biosciences, Inc.$57K
What the payments were for
- Consulting fees$2,75066%
- Food & beverage$1,40234%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shire North American Group Inc | 6 | $2,886 |
| Takeda Pharmaceuticals U.S.A., Inc. | 44 | $532 |
| AstraZeneca | 4 | $195 |
| CSL Behring | 3 | $164 |
| Novartis | 9 | $151 |
| Grifols USA, LLC | 3 | $74 |
| Biocryst US Sales Co., LLC | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| GSK | 2 | $36 |
| Genentech USA, Inc. | 2 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,157 in reported general payments places this provider in the 60th percentile of 320 allergy & immunology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RevcoviElapegademase-Lvlr | 14 | $6,157,632 |
| HyqviaIgg/Hyaluronidase,recombinant | 74 | $900,846 |
| Dupixent SyringeDupilumab | 18 | $64,846 |
| Gammagard S-DImmun Glob G/Gly/Gluc/Iga 0-50 | 18 | $58,514 |
| FlexbuminAlbumin Human | 18 | $29,694 |
| Mycophenolate Mofetil | 16 | $9,248 |
| Epinephrine | 15 | $3,922 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 13 | $201 |
| Levothyroxine Sodium | 14 | $167 |
| Montelukast Sodium | 14 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Hyqvia | $532 | $900,84674 claims |
| Shire North American Group IncFlexbumin | $2,886 | $29,69418 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 320 allergy & immunology providers in New York.
Other allergy & immunology in Bronx
- Tania ElliottBronx$43K
- Golda HudesBronx$29K
- Ujwala KazaNew York$1.1M
- Syed MustafaRochester$948K
- Robert SporterNew York$946K
- Gregory PuglisiPlainview$813K
- Stanley GoldsteinRockville Centre$643K
- Robert TamayevRego Park$321K
- Richard InselNew York$269K
- Payel GuptaBrooklyn$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.